Mortality and Exposure Response Among 14,458 Electrical Capacitor Manufacturing Workers Exposed to Polychlorinated Biphenyls (PCBs)
Overview
Authors
Affiliations
Background: We expanded an existing cohort of workers (n = 2,588) considered highly exposed to polychlorinated biphenyls (PCBs) at two capacitor manufacturing plants to include all workers with at least 90 days of potential PCB exposure during 1939-1977 (n = 14,458). Causes of death of a priori interest included liver and rectal cancers, previously reported for the original cohort, and non-Hodgkin lymphoma (NHL), melanoma, and breast, brain, intestine, stomach, and prostate cancers, based on other studies.
Methods: We ascertained vital status of the workers through 1998, and cumulative PCB exposure was estimated using a new job exposure matrix. Analyses employed standardized mortality ratios (SMRs; U.S., state, and county referents) and Poisson regression modeling.
Results: Mortality from NHL, melanoma, and rectal, breast, and brain cancers were neither in excess nor associated with cumulative exposure. Mortality was not elevated for liver cancer [21 deaths; SMR 0.89; 95% confidence interval (CI), 0.55-1.36], but increased with cumulative exposure (trend p-value = 0.071). Among men, stomach cancer mortality was elevated (24 deaths; SMR 1.53; 95% CI, 0.98-2.28) and increased with cumulative exposure (trend p-value = 0.039). Among women, intestinal cancer mortality was elevated (67 deaths; SMR 1.31; 95% CI, 1.02-1.66), especially in higher cumulative exposure categories, but without a clear trend. Prostate cancer mortality, which was not elevated (34 deaths; SMR 1.04; 95% CI, 0.72-1.45), increased with cumulative exposure (trend p-value = 0.0001).
Conclusions: This study corroborates previous studies showing increased liver cancer mortality, but we cannot clearly associate rectal, stomach, and intestinal cancers with PCB exposure. This is the first PCB cohort showing a strong exposure-response relationship for prostate cancer mortality.
Stathori G, Hatziagapiou K, Mastorakos G, Vlahos N, Charmandari E, Valsamakis G Int J Mol Sci. 2024; 25(21).
PMID: 39518897 PMC: 11545284. DOI: 10.3390/ijms252111344.
Deen L, Hougaard K, Clark A, Meyer H, Frederiksen M, Gunnarsen L Environ Health Perspect. 2022; 130(10):107003.
PMID: 36306207 PMC: 9616107. DOI: 10.1289/EHP10605.
Perrot-Applanat M, Pimpie C, Cano-Sancho G, Antignac J, Pocard M Cancers (Basel). 2021; 13(19).
PMID: 34638358 PMC: 8508119. DOI: 10.3390/cancers13194874.
Donat-Vargas C, Bellavia A, Berglund M, Glynn A, Wolk A, Akesson A J Intern Med. 2019; 287(2):197-209.
PMID: 31628875 PMC: 7003855. DOI: 10.1111/joim.12995.
Ghosh S, Loffredo C, Mitra P, Trnovec T, Murinova L, Sovcikova E Environ Sci Pollut Res Int. 2017; 25(17):16493-16507.
PMID: 29143255 PMC: 5953777. DOI: 10.1007/s11356-017-0149-1.